MAXON/PIXOLOGIC
11.1.2022 19:42:13 CET | Business Wire | Press release
Maxon, developer of professional 3D software solutions, is pleased to announce the completion of all financial and regulatory requirements for the acquisition of all assets of Pixologic, creators of the Academy Award-winning ZBrush sculpting and painting software. As an added benefit, the entire ZBrush team has already joined Maxon, bringing decades of 3D industry expertise. The move suitably rounds out Maxon’s product line and firmly positions the company as an industry leader for providing superior creative tools to digital artists to the €16 billion 3D Animation Industry.*
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110006049/en/
No interruptions are expected for the ongoing development of ZBrush post-acquisition. Nevertheless, the collaboration with Maxon’s development team, access to its other technologies and the potential integrations therein are expected to bring greater innovation and expanded capabilities to ZBrush and the entire Maxon product line. Additionally, the inclusion of the ZBrush team assures greater marketing, training and support resources.
“We are excited to start working with the Maxon team,” said Ofer Alon, Founder and Visionary of Pixologic. “Our synergies are undeniable - both companies share a great tradition of outstanding products, innovation and a passion to serve the creative community.”
“I’m excited to see how this alliance will influence, evolve and enrich all our product offerings,” stated David McGavran, Maxon CEO. “We have our eyes towards not only transforming creative workflows; we’re aspiring to revolutionize the industry.”
Immediate Impact: Pricing and Availability
Until further notice, ZBrush pricing remains unchanged following the completion of the acquisition. Customers can continue to purchase ZBrush through their usual sales channels, including the ZBrush online store.
Please refer to the FAQ for additional information.
*Research and Markets, Global 3D Animation Market Size, Share & Trends Analysis Report by Technique (3D Modeling, Visual Effects), by Component, by Deployment (On-premise, On-demand), by End Use, and Segment Forecasts, 2021-2028, June 2021 - More Info
About ZBrush
ZBrush is used by respected film studios, game developers, designers, advertisers, illustrators, and scientists around the world. The industry’s top creatives have employed ZBrush for nearly every major franchise including Dune, Star Wars, Avatar, the Marvel Cinematic Universe, Game of Thrones, Lord of the Rings/The Hobbit and more. Its versatility has also made it an integral part of animated features such as Frozen, Moana, Raya and the Last Dragon, and Encanto. ZBrush has also been used extensively in Triple A games including Fortnite, the God of War franchise, Uncharted franchise, Assassin's Creed franchise, Far Cry franchise
View source version on businesswire.com: https://www.businesswire.com/news/home/20220110006049/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hologic Signs Definitive Agreement to Acquire Reveal Genomics19.10.2026 21:30:00 CEST | Press release
Acquisition would expand Hologic’s oncology diagnostics portfolio to help inform treatment decisions for more women with breast cancer Hologic, a global leader in women’s health, today announced that it has signed a definitive agreement to acquire Reveal Genomics, a precision oncology company based in Barcelona, Spain, that develops advanced genomic diagnostic tests to help personalized cancer treatment, including its HER2DX test to help optimize therapy for patients with HER2-positive breast cancer. Breast cancer remains one of the most significant health challenges women face today. Reveal Genomics’ tests are highly complementary to Hologic’s existing oncology diagnostics, including the Breast Cancer Index® (BCI) test, the guideline-recognized genomic assay to help inform decisions regarding extended endocrine therapy in women with HR+ early-stage breast cancer. The combination of Hologic’s existing testing with Reveal Genomics’ portfolio represents a significant expansion of Hologic
An Active Role in Freshness: ProAmpac Introduces ProActive Intelligence Shelf Protect19.10.2026 21:27:00 CEST | Press release
ProAmpac, a global leader in flexible packaging and material science, introduces ProActive Intelligence™ Shelf Protect (SP) Series, giving food producers a new way to help preserve product quality and reduce costly spoilage. Designed for select meat, seafood, and dairy applications, the technology is FDA- and USDA-compliant for intended uses in fresh beef, fresh pork, cooked sausage, deli meat, fresh salmon, and fresh cheese. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261019305953/en/ Clearshield®-SP Shrink Bag This direct food-contact biotechnology packaging helps reduce microbial growth associated with food spoilage in intended applications, supporting longer shelf life throughout storage and distribution. Shelf Protect’s patented biotechnology is built directly into food-contact packaging film. “For meat processors, every product lost represents an investment in production, packaging, and distribution that goes unreal
Vedanta Ltd Doubles Zinc Capacity in South Africa with US$ 600 Mn investment19.10.2026 19:19:00 CEST | Press release
Vedanta Limited doubled its annual zinc production capacity to 500,000 tonnes1in South Africa through an investment of nearly US$ 600 Mn at Gamsberg (Phase II) at Vedanta Zinc International (VZI). Gamsberg has one of the world’s most significant zinc deposits and is VZI’s flagship zinc mine. Inaugurated by South African President Cyril Ramaphosa and Vedanta Limited Director Priya Agarwal-Hebbar, this expansion marks one of the decade’s largest mining investments in South Africa. It advances Vedanta Limited’s position as the world’s largest2 zinc producer, with a vision of achieving 3 million tonnes of annual production across India and South Africa. Of this, 2 million tonnes are targeted from its subsidiary, Hindustan Zinc Limited the world’s largest integrated zinc producer, while Vedanta Zinc International business aims to contribute 1 million tonnes annually. This expansion strengthens the ZAR 21 Bn (nearly US$ 1.5 Bn) investment commitment Vedanta made at the 2018 South Africa Inve
Unlocking Digital Gold’s US$700bn Opportunity19.10.2026 18:00:00 CEST | Press release
The digital gold market, worth US$45–55bn today, could unlock up to US$700bn in latent demand, according to new research from World Gold Council and Boston Consulting Group. The report points to substantial untapped appetite among retail investors, with nearly nine in ten surveyed saying they would consider digital gold under the right conditions. The US$700bn opportunity represents the report’s estimate of total latent demand that could be released if today’s barriers to adoption were removed, rather than a near-term forecast. The report’s five-year base case sees digital gold growing by around 27% a year to US$160–170bn by 2031. That could rise to US$270–280bn over the same time if more barriers fall faster. Momentum is already building as financial markets undergo a broader digital transformation, bringing tokenised investment products increasingly into the mainstream. Tokenised gold, one segment of the digital gold market alongside vaulted digital gold, has grown fivefold in value
Roquette Brings Broad Portfolio of Excipient Solutions and Technical Expertise to AAPS PharmSci 360 202619.10.2026 16:00:00 CEST | Press release
Roquette, a global leader in plant-based ingredients, excipients and pharmaceutical solutions, will showcase its expansive portfolio of excipients, capsules, coatings, and biopharma solutions at AAPS PharmSci 360 2026. The conference and trade show will take place October 26-28 in New Orleans, Louisiana, USA. At Booth 1100 in the exhibit hall, Roquette’s Health & Pharma Solutions team will share their expertise across controlled-release technologies, hydroxypropyl beta-cyclodextrins, and sustainable formulation approaches, alongside a comprehensive portfolio of innovative solutions designed to address the evolving needs of pharmaceutical developers. “AAPS PharmSci 360 is a key opportunity to share our latest innovations, as well as highlight the breadth and depth of our scientific know-how that helps our customers solve complex formulation challenges,” said Peter Freed, Head of Technical Service & Development North America for Roquette’s Health & Pharma Solutions Business Unit. “From a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom